
Miguel L Fribourg-Casajuana, PhD
About Me
Miguel Fribourg-Casajuana, PhD, is an engineer and immunologist. His lab focuses on multidisciplinary approaches that combine theoretical and experimental techniques to study cellular signaling in the context of organ transplant immunology with the aim to guide clinical intervention. Dr. Fribourg-Casajuana earned a PhD in Signal Processing from the Polytechnical University in Madrid (UPM), and a PhD in biomedical sciences in a cell-signaling at an electrophysiology lab at the Icahn School of Medicine at Mount Sinai in New York. He did five years of postdoctoral training in systems biology in the field of immunology, where he honed his skills in experimental techniques and computational analyses in functional genomics and studied the effects of type I interferons in early viral infections. Current research interests in the lab include the study of the role of interferon-beta in transplant and the development of new biosensors to monitor regulatory T cell (Treg) activity and function.
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Nephrology, ASSISTANT PROFESSOR | Immunology & Immunotherapy
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Disease Mechanisms and Therapeutics (DMT), Immunology [IMM]
Publications
Selected Publications
- Gamma-Glutamyl Cysteine Ligase Activity as a Proxy for Human T Cell Function and Drug-Induced Immunosuppression. Francisco Fueyo-González, Carmen Salto-Giron, Mehek Ningoo, Laura Espinar-Barranco, Rafael Salto, Jose Manuel Paredes, Rosario Herranz, Angel Orte, Miguel Fribourg, Juan A. González-Vera. Advanced Science
- Metabolic dysregulation in regulatory T cells from patients with immune-mediated glomerular diseases. Johan Noble, Zuzana Macek-Jilkova, Philippe Saas, Paolo Malvezzi, Miguel Fribourg, Leonardo V. Riella, Mario Perez Arnedo, Joaquin Manrique, Paolo Cravedi. Journal of Nephrology
- Patients With Immunoglobulin A Nephropathy Show Abnormal Frequencies of B Cell Subsets, Unconventional T Cells, and High Levels of Galactose-Deficient IgA1–Coated Gut Bacteria. Micaela Gentile, Nina Goerlich, I. Ju Lo, N. Eric Olson, Mark McConnell, Johannes Pospiech, Tobias Bohnenpoll, Philipp Skroblin, Olivier Radresa, Uwe Andag, Kirk N. Campbell, Kristin Meliambro, Luis Sanchez-Russo, Alberto Verlato, Enrico Fiaccadori, Seunghee Kim-Schulze, Maria Lanau, M. Loreto Fernandez-Lorente, Miguel Fribourg, Joaquin Manrique, Paolo Cravedi. Kidney International Reports